![]() |
市場調査レポート
商品コード
1519717
造影剤インジェクター市場レポート:製品タイプ、インジェクタータイプ、用途、エンドユーザー、地域別、2024年~2032年Contrast Media Injectors Market Report by Product Type, Injectors Type, Application, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
造影剤インジェクター市場レポート:製品タイプ、インジェクタータイプ、用途、エンドユーザー、地域別、2024年~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
|
世界の造影剤インジェクター市場規模は2023年に17億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率(CAGR)は5.1%を示し、2032年には27億米ドルに達すると予測しています。慢性疾患の有病率の増加、低侵襲(MI)手技に対する需要の高まり、画像診断手技の増加などが市場を牽引する主な要因です。
造影剤インジェクターは、診断処置中に血管、臓器、組織の可視性を高めるために医療画像診断で使用される必須機器です。造影剤インジェクターは、造影剤用のシリンジまたはリザーバー、注入システム、制御コンソールで構成されます。放射線科医や技師が造影剤を正確かつ均一に注入するために使用します。注入速度と注入量を制御することで、造影剤の最適な分布を確保し、より鮮明で正確な画像を得ることができます。これにより診断の質が向上し、異常や疾患の特定に役立ちます。造影剤注入装置は、画像の鮮明度を高め、再スキャンの必要性を減らし、投与量の制御により患者の安全性を向上させます。造影剤注入装置は、手動注入と比較して、注入速度が安定し、ヒューマンエラーのリスクを低減します。現在、一般的に使用されている製品には、パワーインジェクター、デュアルヘッドインジェクター、シリンジレスインジェクターなどがあります。
世界の造影剤インジェクター市場は、主に慢性疾患の有病率の増加と低侵襲(MI)処置に対する需要の高まりによって後押しされています。これは、画像診断処置の増加によってさらに強化されています。さらに、技術的に先進的な造影剤インジェクターの開発と新興経済諸国における製品採用の拡大が市場成長を促進すると予想されます。これに伴い、主要メーカーはスマートインジェクター、デュアルヘッドインジェクター、統合イメージングシステムなどの革新的な新製品を投入し、製品ラインナップの充実を図っており、市場成長に大きな弾みをつけています。さらに、高齢者人口の増加、急増するヘルスケア支出、効率的で効果的な診断手順への需要の高まりが、市場に明るい見通しをもたらしています。これとは別に、有利な償還政策が利用可能であること、動物医療における造影剤インジェクターの採用が拡大していることも、市場成長に好影響を与えています。さらに、疾患の早期診断と治療への注目の高まりと画像技術の急速な進歩が市場の成長を後押ししています。その他、造影剤の規制承認数の増加やヘルスケア産業の急成長などが市場成長を後押ししています。
The global contrast media injectors market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The increasing prevalence of chronic diseases, the rising demand for minimally invasive (MI) procedures, and the growing number of diagnostic imaging procedures are some of the key factors driving the market.
Contrast media injectors are essential devices used in medical imaging to enhance the visibility of blood vessels, organs, and tissues during diagnostic procedures. They consist of a syringe or reservoir for the contrast media, an injector system, and a control console. They are employed by radiologists and technicians to deliver contrast agents with precision and uniformity. By controlling the rate and volume of injection, they ensure optimal distribution of contrast media, resulting in clearer and more accurate images. This improves the diagnostic quality and helps in identifying abnormalities or diseases. Contrast media injectors help to enhance image clarity, reduce the need for rescans, and improve patient safety due to controlled dosage administration. Compared to manual injections, contrast media injectors offer consistent injection rates and reduce the risk of human error. Currently, the commonly available product variants include power injectors, dual-head injectors, and syringeless injectors.
The global contrast media injectors market is primarily fueled by the increasing prevalence of chronic diseases and the rising demand for minimally invasive (MI) procedures. This is further bolstered by the growing number of diagnostic imaging procedures. Additionally, the development of technologically advanced contrast media injectors and the escalating product adoption in emerging economies are expected to drive the market growth. In line with this, key market players are introducing new and innovative products, including smart injectors, dual-head injectors, and integrated imaging systems, to increase their product portfolio, which is providing a considerable thrust to the market growth. Moreover, the increasing geriatric population, the burgeoning healthcare expenditure, and the growing demand for efficient and effective diagnostic procedures are creating a positive outlook for the market. Apart from this, the availability of favorable reimbursement policies and the escalating adoption of contrast media injectors in veterinary medicine are favoring the market growth. Furthermore, the surging focus on early disease diagnosis and treatment and rapid advancements in imaging technologies are boosting the market growth. Other factors, such as the escalating number of regulatory approvals of contrast agents and the rapid growth in the healthcare industry, are propelling the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global contrast media injectors market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, injectors type, application and end user.
Consumables
Syringes
Tubes
Others
Injector Systems
CT Injectors
MRI Injectors
Angiography Injectors
Accessories
The report has provided a detailed breakup and analysis of the global contrast media injectors market based on the product type. This includes consumables (syringes, tubes, others) and injector systems (CT injectors, MRI injectors, angiography injectors, and accessories). According to the report, the consumables segment accounted for the largest market share.
Single-head Injectors
Dual-head Injectors
Syringeless Injectors
The report has provided a detailed breakup and analysis of the global contrast media injectors market based on the injectors type. This includes single-head injectors, dual-head injectors, and syringeless injectors. According to the report, the single-head injectors segment accounted for the largest market share.
Radiology
Interventional Cardiology
Interventional Radiology
The report has provided a detailed breakup and analysis of the global contrast media injectors market based on the application. This includes radiology, interventional cardiology, and interventional radiology. According to the report, the radiology segment accounted for the largest market share.
Hospitals
Ambulatory Surgery Centers
Diagnostics Imaging Centers
The report has provided a detailed breakup and analysis of the global contrast media injectors market based on the end user. This includes hospitals, ambulatory surgery centers, and diagnostics imaging centers. According to the report, the hospitals segment accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. As per the report, North America was the largest market for contrast media injectors. Some of the factors driving the North America contrast media injectors market include the burgeoning healthcare expenditure, growing demand for efficient and effective diagnostic procedures, and escalating number of regulatory approvals.
The report has also provided a comprehensive analysis of the competitive landscape in the global contrast media injectors market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include APOLLO RT Co. Ltd., Bayer AG, Bracco Imaging S.p.A., General Electric Company, Guerbet, Medtron AG, Nemoto Kyorindo Co. Ltd., Shenzhen Anke High-tech Co. Ltd., Shenzhen Seacrown Electromechanical Co. Ltd., Sino Medical-Device Technology Co. Ltd. and ulrich GmbH & Co. KG. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.